• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

NeuroDerm - Articles and news items


FDA lifts clinical hold on ND0612H and ND0612L for the treatment of Parkinson’s disease

Industry news / 8 May 2015 /

The FDA has lifted the clinical hold on clinical studies of ND0612H and ND0612L, NeuroDerm’s product candidates for the treatment of Parkinson’s disease…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +